A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin

Influenza virus hemagglutinin (HA) mediates receptor binding and viral entry during influenza infection. The development of receptor analogs as viral-entry blockers has not been successful, which suggests that sialic acid may not be an ideal scaffold to obtain broad, potent HA inhibitors. Here, we report crystal structures of Fab fragments from three human antibodies that neutralize the 1957 pandemic H2N2 influenza virus in complex with H2 HA. All three antibodies use an aromatic residue to plug a conserved cavity in the HA receptor-binding site. Each antibody interacts with the absolutely conserved HA1 Trp153 at the cavity base through π-π stacking with the signature Phe54 of two VH1-69–encoded antibodies or a tyrosine from HCDR3 in the other antibody. This highly conserved interaction can be used as a starting point to design inhibitors targeting this conserved hydrophobic pocket in influenza viruses.

[1]  K. Henrick,et al.  Inference of macromolecular assemblies from crystalline state. , 2007, Journal of molecular biology.

[2]  I. Wilson,et al.  Broadly neutralizing antibodies against influenza virus and prospects for universal therapies. , 2012, Current opinion in virology.

[3]  J. Paulson.  Interactions of Animal Viruses with Cell Surface Receptors , 1985 .

[4]  John Steel,et al.  Cross-neutralization of influenza A viruses mediated by a single antibody loop , 2012, Nature.

[5]  A. Langmuir,et al.  Excess mortality from epidemic influenza, 1957-1966. , 1974, American journal of epidemiology.

[6]  R. Webby,et al.  Identification of H2N3 influenza A viruses from swine in the United States , 2007, Proceedings of the National Academy of Sciences.

[7]  J. Crowe,et al.  Human Monoclonal Antibodies to Pandemic 1957 H2N2 and Pandemic 1968 H3N2 Influenza Viruses , 2012, Journal of Virology.

[8]  K. Neve.  A Receptors , 2021, Encyclopedia of Molecular Pharmacology.

[9]  I. Wilson,et al.  Structure, Receptor Binding, and Antigenicity of Influenza Virus Hemagglutinins from the 1957 H2N2 Pandemic , 2009, Journal of Virology.

[10]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[11]  G. Russo,et al.  Hepatitis C Virus Drives the Unconstrained Monoclonal Expansion of VH1–69-Expressing Memory B Cells in Type II Cryoglobulinemia: A Model of Infection-Driven Lymphomagenesis 1 , 2005, The Journal of Immunology.

[12]  Wayne A Hendrickson,et al.  Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[13]  James E Crowe,et al.  Epitope-Specific Human Influenza Antibody Repertoires Diversify by B Cell Intraclonal Sequence Divergence and Interclonal Convergence , 2011, The Journal of Immunology.

[14]  J. Overbaugh,et al.  Human Immunodeficiency Virus Type 1 V1-V2 Envelope Loop Sequences Expand and Add Glycosylation Sites over the Course of Infection, and These Modifications Affect Antibody Neutralization Sensitivity , 2006, Journal of Virology.

[15]  Boguslaw Stec,et al.  Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses , 2009, Nature Structural &Molecular Biology.

[16]  Tongqing Zhou,et al.  Structural definition of a conserved neutralization epitope on HIV-1 gp120 , 2007, Nature.

[17]  Randy J Read,et al.  Electronic Reprint Biological Crystallography Likelihood-enhanced Fast Translation Functions Biological Crystallography Likelihood-enhanced Fast Translation Functions , 2022 .

[18]  S. Gilbert.  Advances in the development of universal influenza vaccines , 2012, Influenza and other respiratory viruses.

[19]  A. Takada,et al.  Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity , 2012, Proceedings of the National Academy of Sciences.

[20]  Y. Iba,et al.  Naturally Occurring Antibodies in Humans Can Neutralize a Variety of Influenza Virus Strains, Including H3, H1, H2, and H5 , 2011, Journal of Virology.

[21]  S. Cusack,et al.  Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid , 1988, Nature.

[22]  R. Webster,et al.  Cross-protection and reassortment studies with avian H2 influenza viruses , 2000, Archives of Virology.

[23]  I. Wilson,et al.  Structural basis of immune recognition of influenza virus hemagglutinin. , 1990, Annual review of immunology.

[24]  G M Whitesides,et al.  Hemagglutinins from two influenza virus variants bind to sialic acid derivatives with millimolar dissociation constants: a 500-MHz proton nuclear magnetic resonance study. , 1989, Biochemistry.

[25]  Randy J Read,et al.  Electronic Reprint Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination , 2022 .

[26]  Noriko Kishida,et al.  Cross-Protective Potential of a Novel Monoclonal Antibody Directed against Antigenic Site B of the Hemagglutinin of Influenza A Viruses , 2009, PLoS pathogens.

[27]  R. Webster,et al.  Characterization of H2 influenza virus hemagglutinin with monoclonal antibodies: influence of receptor specificity. , 1984, Virology.

[28]  H. Klenk,et al.  Natural and synthetic sialic acid‐containing inhibitors of influenza virus receptor binding , 2003, Reviews in medical virology.

[29]  C. W. Hilbers,et al.  A 500-MHz proton nuclear magnetic resonance study of the structure and structural alterations of gene-5 protein-oligo(deoxyadenylic acid) complexes. , 1983, Biochemistry.

[30]  W. J. Bean,et al.  Origin of the pandemic 1957 H2 influenza A virus and the persistence of its possible progenitors in the avian reservoir. , 1993, Virology.

[31]  Y. Isegawa,et al.  A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains , 1993, Journal of virology.

[32]  R. Marasca,et al.  Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma. , 2001, The American journal of pathology.

[33]  Surender Khurana,et al.  Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin , 2011, Proceedings of the National Academy of Sciences.

[34]  J. Skehel,et al.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. , 2000, Annual review of biochemistry.

[35]  V. Shepherd,et al.  Virus glycosylation: role in virulence and immune interactions , 2007, Trends in Microbiology.

[36]  S. Levy,et al.  V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen. , 2001, Blood.

[37]  Gira Bhabha,et al.  Antibody Recognition of a Highly Conserved Influenza Virus Epitope , 2009, Science.

[38]  I. Wilson,et al.  Structural Characterization of the Hemagglutinin Receptor Specificity from the 2009 H1N1 Influenza Pandemic , 2011, Journal of Virology.

[39]  Huan‐Xiang Zhou,et al.  Recent progress in structure-based anti-influenza drug design. , 2012, Drug discovery today.

[40]  James E. Crowe,et al.  Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus , 2010, Science.

[41]  M. Luftig,et al.  Structural basis for HIV-1 neutralization by a gp41 fusion intermediate–directed antibody , 2006, Nature Structural &Molecular Biology.

[42]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[43]  Serfling Re,et al.  EXCESS PNEUMONIA-INFLUENZA MORTALITY BY AGE AND SEX IN THREE MAJOR INFLUENZA A2 EPIDEMICS, UNITED STATES, 1957–58, 1960 AND 1963 , 1967 .

[44]  L. Simonsen,et al.  Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. , 1998, The Journal of infectious diseases.

[45]  J. Skehel,et al.  Structures of receptor complexes formed by hemagglutinins from the Asian Influenza pandemic of 1957 , 2009, Proceedings of the National Academy of Sciences.

[46]  John Steel,et al.  Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies , 2008, Proceedings of the National Academy of Sciences.

[47]  Chih-Jen Wei,et al.  Vaccinate for the next H2N2 pandemic now , 2011, Nature.

[48]  R. Serfling,et al.  Excess pneumonia-influenza mortality by age and sex in three major influenza A2 epidemics, United States, 1957-58, 1960 and 1963. , 1967, American journal of epidemiology.